Star51 Capital is a venture investment platform bridging the gap between innovation and acquisition. Anchored by a leading healthcare system and a global Medtech strategic, we invest at the convergence of Medtech and AI.
Star51 Capital is a venture investment vehicle designed to bridge the gap between innovation and acquisition. Anchored by a leading healthcare system and a top-tier global Medtech strategic, the fund focuses specifically on the convergence of Medtech and AI, leveraging deep industry ties to accelerate market entry and liquidity.
Leading healthcare system and a top-5 global Medtech strategic providing clinical validation, commercialization pathways, and domain expertise beyond capital.
Managed by founders turned investors who have built, scaled, and exited Medtech companies. We understand the acquirer's mind.
High-conviction opportunities sourced from the US, Europe, and Israel at the intersection of Medtech and AI.
An integrated ecosystem that bridges the gap between innovation and acquisition, building companies that are both acquirable and in high demand by strategics.

CFO for high-growth Medtech startups including Axon, Coridea, and Deerfield Catalyst. Expert in navigating complex financial structures and venture scaling. Berklee College of Music, Wharton MBA.

Founder of Corindus Vascular Robotics. Led the company through its full lifecycle to a $1.1B acquisition by Siemens Healthineers. Former Venture Partner for a global Medtech strategic.











